Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Combination Chemotherapy in Treating Pediatric Patients With Advanced-Stage Large Cell Lymphoma
The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2008
by National Cancer Institute (NCI).
Recruitment status was Active, not recruiting
Study NCT00002618 Information provided by National Cancer Institute (NCI)
First Received on November 1, 1999. Last Updated on February 6, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Lymphoma
Additional conditions recognized in this trial
Lymphoma, Large-Cell, Immunoblastic
Lymphoma, Non-Hodgkin
More general conditions related to this trial
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
Interventions listed in this trial
filgrastim
cytarabine
doxorubicin hydrochloride
leucovorin calcium
mercaptopurine
methotrexate
prednisone
vincristine sulfate
low-LET cobalt-60 gamma ray therapy
low-LET electron therapy
low-LET photon therapy
Additional drug interventions recognized in this trial
6-Mercaptopurine
Doxorubicin
Lenograstim
Leucovorin
Levoleucovorin
Vincristine
More general drug interventions related to this trial
Abortifacient Agents
Abortifacient Agents, Nonsteroidal
Adjuvants, Immunologic
Anti-Infective Agents
Anti-Inflammatory Agents
Antibiotics, Antineoplastic
Antidotes
Antimetabolites
Antimetabolites, Antineoplastic
Antimitotic Agents
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Antineoplastic Agents, Phytogenic
Antirheumatic Agents
Antiviral Agents
Dermatologic Agents
Enzyme Inhibitors
Folic Acid Antagonists
Glucocorticoids
Growth Substances
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Immunologic Factors
Immunosuppressive Agents
Micronutrients
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Nucleic Acid Synthesis Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Reproductive Control Agents
Therapeutic Uses
Tubulin Modulators
Vitamin B Complex
Vitamins
Sponsors listed in this trial
Pediatric Oncology Group
National Cancer Institute (NCI)
Back to top of Main Content
